Amikacin Impurities

A number of bacterial illnesses are treated with the antibiotic amikacin.

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Amikacin Amikacin EP Impurity A VL6230001View CAS 50725-24-1
Amikacin Amikacin EP Impurity B VL6230002View CAS 927821-99-6
Amikacin Amikacin EP Impurity C VL6230003View CAS 50725-25-2
Amikacin Amikacin EP Impurity D VL6230004View CAS 59-01-8
Amikacin Amikacin EP Impurity E VL6230005View CAS 50866-72-3
Amikacin Amikacin EP Impurity E (Sulfate Salt) VE0011342View
Amikacin Amikacin EP Impurity F VL6230006View CAS 197909-67-4
Amikacin Amikacin EP Impurity G VL6230007View CAS 50896-99-6
Amikacin Amikacin EP Impurity H VL6230008View CAS 48237-20-3
Amikacin Amikacin EP Impurity H (Sulphate Salt) / Amikacin B Sulfate VE0010172View
Amikacin Amikacin EP Impurity I VE007961View CAS 40371-51-5
Amikacin 1, 3’’-Di-HABA Kanamycin A VE009648View CAS 197909-66-3
View CAS

Amikacin Related Compound

This includes urinary tract infections, meningitis, pneumonia, intraabdominal infections, and joint infections. Moreover, it is used to treat multi-drug-resistant TB.

FAQ

Amikacin kills what types of bacteria?

Amikacin has excellent efficacy against the majority of aerobic gram-negative bacilli from the Enterobacteriaceae family, including Nocardia and certain Mycobacteria (M. avium-intracellulare, M. chelonae, and M. fortuitum)

Is amikacin used for UTI?

Amikacin is a powerful aminoglycoside that works well against bacteria that produce extended-spectrum beta-lactamase (ESBL). UTIs are more common in older patients, especially in fragile nursing home residents, and resistant bacterial infections are more common in older patients.

Is amikacin used for pneumonia?

Researchers examine 73 case reports of patients with gram-negative pneumonia who received amikacin from investigators who submitted them to the company. Amikacin and gentamicin were both effective against all isolated pathogens. (74%) of these patients improved after receiving amikacin therapy.

Request a quote

197909-66-3: 1,3’’-Di-HABA Kanamycin A

197909-66-3: 1,3’’-Di-HABA Kanamycin A
Catalogue No.

VE009648
CAS No.

197909-66-3
Molecular Formula

C26H50N6O15
Molecular Weight

686.71 g/mol
Parent drug

Amikacin
IUPAC Name

(S)-4-amino-N-((1R, 2S, 3S, 4R, 5S)-5-amino-2-(((2S, 3R, 4S, 5S, 6R)-4-((S)-4-amino-2-hydroxybutanamido)-3, 5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R, 3R, 4S, 5S, 6R)-6-(aminomethyl)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
Synonyms

N/A
References

Taylor, L. A., & Rose, R. E. (1988). A correction in the nucleotide sequence of the Tn903 kanamycin resistance determinant in pUC4K. Nucleic Acids Research, 16(1), 358–358. https://doi.org/10.1093/nar/16.1.358
Status

In-stock
ListName

1, 3’’-Di-HABA Kanamycin A
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url